Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alcon, Inc.
Alcon's First Quarter Sales Rise 16.2 Percent; Net Income Increases 24.0 Percent
May 11th, 2008
Alcon, Inc. (NYSE:ACL) reported global sales of $1,536.4 million for the first quarter of 2008, an increase of 16.2 percent compared to the first quarter of 2007, or 9.4 percent excluding the impact of foreign exchange fluctuations. Net earnings for the first quarter of 2008 increased 24.0 percent to $429.4 million, or $1.43 per share on a diluted basis, compared to $346.2 million, or $1.14 per share for the first quarter of 2007. "Our strong results for the first quarter came from continuing market share gains for our major pharmaceutical brands, our strong performance in Japan with several new pharmaceutical products, rapid growth in sales of our advanced technology...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-11)
|
